Clinical Trial Update: Efficacy of Rifaximin With NAC in IBS-D [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy of rifaximin in combination with N-acetylcysteine for diarrhea-predominant irritable bowel syndrome (IBS-D); curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome
• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• Rifaximin (rifaximin)

Snippet

Sponsor: Mark Pimentel, MD | Conditions: IBS (Irritable Bowel Syndrome), IBS-D (Diarrhea-predominant) | Phase 2 | Status: RECRUITING